UNSPSC 51182002: Testosterone

This classification denotes an androgen with the molecular formula C19H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3XMK78S47O, chemically known as 10.alpha.-androst-4-en-3-one, 17.beta.-hydroxy- but generally known as testosterone, which bears US NIH Compound Identifier 5408. European Medicines Agency schedules Testosterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10937MIG.

UNSPSC 51182002 Testosterone, a Commodity code, covers hormonal pharmaceutical products including testosterone preparations that state and local government health agencies procure for institutional distribution through cooperative purchasing arrangements. The solicitation activity under this code reflects broader demand for generic and branded pharmaceuticals within state health systems, correctional facilities, mental health institutions, and other public sector medical settings. State agencies and regional cooperative purchasing alliances are the primary issuing bodies, with multistate cooperative agreements serving as the dominant procurement vehicle to aggregate demand and negotiate pricing across multiple jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products including testosterone formulations, with awarded vendors effective July 1, 2026. The procurement requires vendors to supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and mandates compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. Evaluation weights pricing competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing (10 percent), price format compliance (5 percent), EDI capability (5 percent), and administrative fee agreement (5 percent). Vendors must maintain commercial general liability insurance of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000. The contract term extends two years for new responders with optional extensions, while incumbent responders' amendments align through June 30, 2028. MMCAP reserves multi-award discretion based on therapeutic considerations, product availability, and member-specific needs, with participating members including Minnesota and Oregon.